Replies to post #124729 on Cytodyn Inc (CYDY)

[Whosonfirst]

Smallest risk of any stock when comparing risk benefit analysis. I’ve evaluated hundreds of stocks and although many may be safer they also do not carry any of the huge catalyst CYDY has in its tool box. The share price increase factor vs the risk of not getting HIV or Covid approval are light years apart 95% chance hiv Approval 99.9% chance in my option of getting either COVID or HIV approvals and 85% chance we get approval for both. 0.001% that we don’t get approval for either in my opinion. There you have it folks risk benefit analysis, if you let shirts scare you out of your position you will lose money, set it and forget it your gonna be waking up to huge lumps of money very soon ... Don’t Blink